EFN.TO vs. RYTM
EFN.TO (Element Fleet Management Corp.) and RYTM (Rhythm Pharmaceuticals, Inc.) are both stocks. EFN.TO operates in Rental & Leasing Services (Industrials), while RYTM operates in Biotechnology (Healthcare). Over the past 5 years, EFN.TO returned 16.91%/yr vs 40.05%/yr for RYTM. At a 0.13 correlation, their price movements are largely independent.
Performance
EFN.TO vs. RYTM - Performance Comparison
Loading charts...
Different Trading Currencies
EFN.TO is traded in CAD, while RYTM is traded in USD. To make them comparable, the RYTM values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, EFN.TO achieves a -25.54% return, which is significantly lower than RYTM's -18.01% return.
EFN.TO
- 1D
- 2.73%
- 1M
- -13.76%
- YTD
- -25.54%
- 6M
- -26.11%
- 1Y
- -15.02%
- 3Y*
- 11.88%
- 5Y*
- 16.91%
- 10Y*
- 10.74%
RYTM
- 1D
- -1.17%
- 1M
- -8.57%
- YTD
- -18.01%
- 6M
- -16.66%
- 1Y
- 33.08%
- 3Y*
- 72.97%
- 5Y*
- 40.05%
- 10Y*
- —
EFN.TO vs. RYTM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EFN.TO Element Fleet Management Corp. | -25.54% | 26.00% | 37.37% | 19.41% | 46.54% | -1.75% | 22.92% | 63.45% | -23.56% | 5.92% |
RYTM Rhythm Pharmaceuticals, Inc. | -18.01% | 82.44% | 32.24% | 54.39% | 212.58% | -66.73% | 27.30% | -18.78% | 0.34% | -3.02% |
Correlation
The correlation between EFN.TO and RYTM is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Oct 6, 2017 | 0.13 |
Fundamentals
EFN.TO:
CA$10.64B
RYTM:
$5.87B
EFN.TO:
CA$0.73
RYTM:
-$3.10
EFN.TO:
4.53
RYTM:
26.15
EFN.TO:
3.94
RYTM:
716.57
EFN.TO:
CA$2.36B
RYTM:
$217.17M
EFN.TO:
CA$1.03B
RYTM:
$194.16M
EFN.TO:
CA$1.56B
RYTM:
-$182.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EFN.TO vs. RYTM — Risk / Return Rank
EFN.TO
RYTM
EFN.TO vs. RYTM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Element Fleet Management Corp. (EFN.TO) and Rhythm Pharmaceuticals, Inc. (RYTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EFN.TO | RYTM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.29 | ||
| Sortino ratioReturn per unit of downside risk | -2.27 | ||
| Omega ratioGain probability vs. loss probability | 0.89 | 1.17 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.53 | 0.95 | -1.48 |
| Martin ratioReturn relative to average drawdown | -1.43 | 2.19 | -3.63 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EFN.TO | RYTM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.71 | 0.58 | -1.29 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.72 | 0.53 | +0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.31 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.20 | +0.31 |
Drawdowns
EFN.TO vs. RYTM - Drawdown Comparison
The maximum EFN.TO drawdown since its inception was -75.03%, smaller than the maximum RYTM drawdown of -92.04%. Use the drawdown chart below to compare losses from any high point for EFN.TO and RYTM.
Loading charts...
Drawdown Indicators
| EFN.TO | RYTM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.03% | -92.04% | +17.01% |
Max Drawdown (1Y)Largest decline over 1 year | -31.19% | -34.97% | +3.78% |
Max Drawdown (3Y)Largest decline over 3 years | -31.19% | -34.97% | +3.78% |
Max Drawdown (5Y)Largest decline over 5 years | -31.19% | -84.72% | +53.53% |
Max Drawdown (10Y)Largest decline over 10 years | -72.13% | — | — |
Current DrawdownCurrent decline from peak | -29.31% | -25.64% | -3.67% |
Average DrawdownAverage peak-to-trough decline | -15.94% | -31.28% | +15.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.46% | 15.11% | -3.65% |
Volatility
EFN.TO vs. RYTM - Volatility Comparison
The current volatility for Element Fleet Management Corp. (EFN.TO) is 11.74%, while Rhythm Pharmaceuticals, Inc. (RYTM) has a volatility of 14.48%. This indicates that EFN.TO experiences smaller price fluctuations and is considered to be less risky than RYTM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EFN.TO | RYTM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.74% | 14.48% | -2.74% |
Volatility (6M)Calculated over the trailing 6-month period | 19.69% | 36.45% | -16.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.27% | 57.39% | -34.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.66% | 75.73% | -52.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.92% | 70.24% | -35.32% |
Dividends
EFN.TO vs. RYTM - Dividend Comparison
EFN.TO's dividend yield for the trailing twelve months is around 2.02%, while RYTM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EFN.TO Element Fleet Management Corp. | 2.02% | 1.44% | 1.69% | 1.95% | 1.81% | 2.12% | 1.49% | 1.62% | 3.91% | 3.16% | 0.80% | 0.19% |
RYTM Rhythm Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
EFN.TO vs. RYTM - Financials Comparison
This section allows you to compare key financial metrics between Element Fleet Management Corp. and Rhythm Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EFN.TO vs. RYTM - Profitability Comparison
EFN.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Element Fleet Management Corp. reported a gross profit of 202.63M and revenue of 598.29M. Therefore, the gross margin over that period was 33.9%.
RYTM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a gross profit of 52.96M and revenue of 60.11M. Therefore, the gross margin over that period was 88.1%.
EFN.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Element Fleet Management Corp. reported an operating income of 252.90M and revenue of 598.29M, resulting in an operating margin of 42.3%.
RYTM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported an operating income of -52.36M and revenue of 60.11M, resulting in an operating margin of -87.1%.
EFN.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Element Fleet Management Corp. reported a net income of 116.60M and revenue of 598.29M, resulting in a net margin of 19.5%.
RYTM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a net income of -56.74M and revenue of 60.11M, resulting in a net margin of -94.4%.
Frequently Asked Questions
EFN.TO and RYTM have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for EFN.TO and RYTM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer